Back to KROS

MACKENZIE FINANCIAL CORP → KROS

MACKENZIE FINANCIAL CORP KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$8.5M
Q3 2026
Peak value
$8.5M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$898K
Q4 2025$1M
Q1 2026$1.7M
Q2 2026$6.7M
Q3 2026$8.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$8.5M742.8K——
Q2 2026$6.7M628.4K——
Q1 2026$1.7M152.4K——
Q4 2025$1M51.4K——
Q3 2025$898K56.8K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other MACKENZIE FINANCIAL CORP positions

RYLBF

Royal Bank of Canada

$5.5B
TDBCP

Toronto-Dominion Bank/The

$3.9B
RYLBF

ROYAL BK CDA

$3.6B
NVDA

NVIDIA Corp

$3.5B
RYLBF

Royal Bank of Canada

$3.5B
RYLBF

ROYAL BK CDA

$3.2B
RYLBF

ROYAL BK CDA

$3.1B
MSFT

MICROSOFT CORP

$3.1B